Barr confirms patent challenge of Amrix extended-release capsules
Barr has filed its abbreviated new drug application (ANDA) containing a paragraph IV certification for a generic version of Amrix with the FDA, and following receipt of the

Barr has filed its abbreviated new drug application (ANDA) containing a paragraph IV certification for a generic version of Amrix with the FDA, and following receipt of the

The transaction is contingent on the closing of the acquisition of Datascope by Getinge, a provider of infection control equipment and systems, as well as the satisfaction of

Prior to his board election, Mr Equels served as Hemispherx BioPharma’s litigation counsel. Mr Equels’s legal practice is devoted to litigation, with particular emphasis on civil racketeering, business

Bupropion hydrochloride extended-release tablets are the generic equivalent to GlaxoSmithKline’s Wellbutrin XL product, which is indicated for the treatment of major depressive disorder. Watson intends to launch the

According to the company, data from a four-year post-implantation multi-center European study, performed in Greece, Poland and Austria, showed that Aorfix provides significant annual shrinkage (8% to 16%)

David Enloe, Jr, formerly Introgen’s senior vice president of operations, has been named president and CEO of the company, succeeding Mr Nance, who will continue in his role

Most recently, Mr Velmer was senior vice president of Western Europe at Merck Serono in Frankfurt, Germany, where he was responsible for the management of 16 countries across

Diagnostics to rapidly screen individual patients for influenza virus in hospitals, clinics and doctors’ offices, personal protection devices such as facemasks to help stop the spread of disease,

In this role, Dr Leoprechting will be responsible for driving the cellular imaging business for PerkinElmer. Prior to his new appointment, Dr Leoprechting was the European sales director

Until a successor is elected, Mr Falvey’s responsibilities will be assumed by Neal Armstrong, who served as Aspect’s CFO from 1996 to 2005. Mr Falvey will assist Mr